BioAgilytix Named to Inc. Magazine’s 2017 Inc. 5000 List of Fastest-Growing Private U.S. Companies

The Bioanalytical Laboratory Earns Spot in Exclusive Ranking for the Fourth Time in Five Years

August 16, 2017—Durham, NC—BioAgilytix, a leading provider of contract bioanalytical testing services with specialization in large molecule bioanalysis, has been named to Inc. Magazine’s Inc. 5000 list of the fastest-growing private companies in the nation for 2017. The prestigious list recognizes trailblazing companies that are private, for-profit, and independent, and that have realized remarkable growth over the last three years. Companies are ranked by their percentage growth of annual revenue during that time, and BioAgilytix jumped 922 spots from its previous ranking in 2016 to land among the most innovative entrepreneurial businesses in the country.

This is the fourth time in five years that BioAgilytix has made an appearance on the Inc. 5000 list, coming in at #1341 in 2013 and #1943 in 2014 into addition to its more recent rankings in 2016 and 2017. The company’s consistent, measured growth reflects its team’s continuous commitment to providing best-in-class large molecule bioanalysis to pharmaceutical and biotechnology companies worldwide. In a constantly evolving, highly innovative field, the rankings prove that BioAgilytix has been able to remain on the leading edge of biotherapeutics research and development, and is successfully meeting increased customer demands for preclinical, clinical, and manufacturing support for immunogenicity, pharmacokinetic, cell-based assay, and biomarker studies.

“We are proud to be named to the Inc. 5000 list for a fourth time. Only one in ten companies of the tens of thousands that apply have managed to achieve this, which is really a testament to the dedication of our team and differentiated partnerships we forge with our clients,” said Jim Datin, President and Chief Executive Officer of BioAgilytix. “Since our founding nine years ago, our mission has been to help our clients more effectively and efficiently bring life-changing products to the market. It’s exciting to see that mission being fulfilled here each day, and to have our team’s successes reflected in our continued growth—growth which in turn enables us to support more customers and help better the lives of the patients they serve.”

In addition to being profiled on Inc.com, all listed companies will also be honored at the Inc. 5000 Conference and Gala held October 10 through 12, 2017 in Palm Desert, California.

###

About BioAgilytix

BioAgilytix is a leading global bioanalytical testing laboratory specializing in large molecule bioanalysis. With laboratory locations in North Carolina’s Research Triangle area and Hamburg, Germany, BioAgilytix provides PK, immunogenicity, biomarkers, and cell-based assay services supporting the development and release testing of biologics across a number of industries and disease states. BioAgilytix offers assay development, validation, and sample analysis under non-GLP, spirit-of-GLP, GLP, and GCP, as well as product release testing under GMP.

BioAgilytix’s team of highly experienced scientific and QA professionals ensures high quality science, data integrity, and regulatory compliance through all phases of clinical development, and is a trusted partner to 23 of the top 25 global pharmaceutical and biotech companies. For more information, visit www.bioagilytix.com.

Media Contact:
Carla Nieser
Vovéo Marketing Group
610.240.0400, x 118
c.nieser@voveo.com

Share This